Search Results - "Bij de Weg, Jeske M."

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2

    Hypertensive disorders of pregnancy after multifetal pregnancy reduction: a systematic review and meta-analysis by van Baar, Petra M., Bij de Weg, Jeske M., ten Hove, Eibert A., Schoonmade, Linda J., van de Mheen, Lidewij, Pajkrt, Eva, de Groot, Christianne J.M., de Boer, Marjon A.

    Published in Hypertension in pregnancy (31-12-2023)
    “…To systematically review the literature on hypertensive disorders of pregnancy (HDP) after multifetal pregnancy reduction (MFPR). A comprehensive search in…”
    Get full text
    Journal Article
  3. 3

    Implementation of aspirin use during pregnancy in community midwifery-led care in the Netherlands: A pilot survey by Bij de Weg, Jeske M, van Doornik, Rebecca, van den Auweele, Kim L H E, de Groot, Christianne J M, de Boer, Marjon A, de Vries, Johanna I P

    Published in European journal of midwifery (01-08-2024)
    “…Aspirin nowadays is widely used in pregnancy, but implementation among gynecologists took nearly four decades. For a complete insight in the implementation of…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The value of a mobile educative Application additional to Standard counselling on aspirin Adherence in Pregnancy: the ASAP study, a randomised controlled trial by bij de Weg, Jeske M., de Boer, Marjon A., Meijer, Cynthia, Lugtenburg, Noëlle, Melles, Marijke, de Vries, Johanna I.P., de Groot, Christianne J.M.

    Published in PEC innovation (01-12-2024)
    “…To assess the added value of a novel, mobile educative application to standard counselling on aspirin adherence during pregnancy versus standard counselling…”
    Get full text
    Journal Article
  6. 6

    Patients' perspective on aspirin during pregnancy: a survey by bij de Weg, Jeske M., Abheiden, Carolien N. H., de Boer, Marjon A., de Groot, Conni, de Vries, Johanna I. P.

    Published in Hypertension in pregnancy (01-10-2020)
    “…To elucidate patients' knowledge and counseling perspective on aspirin reducing the risk of hypertensive disorders of pregnancy (HDP). A quantitative survey…”
    Get full text
    Journal Article
  7. 7

    Resistance of aspirin during and after pregnancy: A longitudinal cohort study by bij de Weg, Jeske M., Abheiden, Carolien N.H., Fuijkschot, Wessel W., Harmsze, Ankie M., de Boer, Marjon A., Thijs, Abel, de Vries, Johanna I.P.

    Published in Pregnancy hypertension (01-01-2020)
    “…•Aspirin reduces the risk of hypertensive disorders of pregnancy (HDP).•Aspirin resistance might hinder the risk reduction of HDP.•This is the first study to…”
    Get full text
    Journal Article
  8. 8

    Recovery of second trimester pre-eclampsia after fetal reduction of a triplet by bij de Weg, Jeske M, de Groot, Christianne J, Pajkrt, Eva, de Boer, Marjon A

    Published in BMJ case reports (01-09-2019)
    “…Women with a multiple pregnancy are at increased risk of developing hypertensive disorders of pregnancy. We describe a case of a dichorionic triamniotic…”
    Get full text
    Journal Article
  9. 9
  10. 10

    The effect of low-dose aspirin on platelet function during pregnancy compared to placebo: An explorative study by bij de Weg, Jeske M., Landman, Anadeijda J.E.M.C., de Vries, Johanna I.P., Thijs, Abel, Harmsze, Ankie M., Oudijk, Martijn A., de Boer, Marjon A.

    “…•Aspirin is used for prevention of preeclampsia and other obstetric complications.•Aspirin treatment failure could be attributable to resistance or…”
    Get full text
    Journal Article
  11. 11

    Optimal treatment for women with acute hypertension in pregnancy; a randomized trial comparing intravenous labetalol versus nicardipine by bij de Weg, Jeske M., de Boer, Marjon A., Gravesteijn, Benjamin Y., Hermes, Wietske, Ganzevoort, Wessel, van Bel, Frank, Willem Mol, Ben, de Groot, Christianne J.M.

    Published in Pregnancy hypertension (01-12-2024)
    “…•Severe hypertension is a serious complication of pregnancy.•The optimal treatment for women with severe hypertension in pregnancy is not known.•Labetalol has…”
    Get full text
    Journal Article